Clinical trial
Observational Study in Patients With Schizophrenia Treated With Long-Acting…
NCT00246194 · Janssen, LP, Industry · Completed
Key facts
| NCT number | NCT00246194 |
|---|---|
| Title | Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA) |
| Official title | The SOURCE Study: Schizophrenia Outcomes-utilization, Relapse, and Clinical Evaluation: a Prospective 2-year Observational Study of Patients With Schizophrenia Who Initiate Treatment With Injectable Risperidone Long-acting Microspheres (RISPERDAL CONSTA) |
| Acronym | SOURCE |
| Lead sponsor | Janssen, LP, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | risperidone (RISPERDAL CONSTA) |
| Enrollment | 532 |
| Start date | Sep 1, 2004 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Oct 31, 2005 |
| Last update posted | Apr 4, 2014 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: